Open AccessHigh-Speed Characterization of Vocal Fold Vibrations in Normally Cycling and Postmenopausal Women: Randomized Double-Blind Analyses
Author(s) -
Rita R. Patel,
Mary J. Sandage,
Heidi A. Kluess,
Laura W. Plexico
Publication year - 2021
Publication title -
journal of speech, language, and hearing research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.958
H-Index - 138
eISSN - 1558-9102
pISSN - 1092-4388
DOI - 10.1044/2021_jslhr-20-00706
Subject(s) - phonation , luteal phase , follicular phase , menstrual cycle , medicine , exhalation , hormone , testosterone (patch) , vocal folds , endocrinology , larynx , audiology , anesthesia , surgery
Purpose The aim of this study was to examine the influence of menstrual cycle phases (follicular, ovulatory, luteal, and ischemic) and hormone levels (estradiol, testosterone, progesterone, and neuropeptide Y) on vocal fold vibrations in reproductive and postmenopausal women. Method Glottal area waveforms were extracted from high-speed videoendoscopy during sustained phonation, inhalation phonation, and voice onset/offset in the reproductive ( n = 15) and postmenopausal ( n = 13) groups. Linear mixed-model analysis was conducted to evaluate hormone levels and high-speed videoendoscopy outcome variables between the reproductive and postmenopausal groups. In the reproductive group, simple linear regression and multiple regression were conducted to determine the effects of hormones on the dependent variables. Results Group differences between reproductive and postmenopausal women were identified for stiffness index, oscillatory onset time, and oscillatory offset time. Neuropeptide Y hormone in the ischemic phase significantly predicted changes in the reproductive group for some dependent variables; however, the relationship varied for sustained phonation and inhalation phonation. Conclusion These findings provide preliminary evidence that vocal fold vibrations in the reproductive group are different predominantly in the ischemic phase due to neuropeptide Y changes.